首页> 外文期刊>Industrial and organizational psychology >Preoperative miRNA-208a as a Predictor of Postoperative Complications in Children with Congenital Heart Disease Undergoing Heart Surgery
【24h】

Preoperative miRNA-208a as a Predictor of Postoperative Complications in Children with Congenital Heart Disease Undergoing Heart Surgery

机译:术前miRNA-208a作为患有先天性心脏病的儿童术后并发症的预测因子

获取原文
获取原文并翻译 | 示例
           

摘要

Major perioperative cardiovascular events are important causes of morbidity in pediatric patients with congenital heart disease who undergo reparative surgery. Current preoperative clinical risk assessment strategies have poor accuracy for identifying patients who will sustain adverse events following heart surgery. There is an ongoing need to integrate clinical variables with novel technology and biomarkers to accurately predict outcome following pediatric heart surgery. We tested whether preoperative levels of miRNAs-208a can serve as such a biomarker. Serum samples were obtained from pediatric patients immediately before heart surgery. MiRNA-208a was quantified by RQ-PCR. Correlations between the patient's clinical variables and miRNA levels were tested. Lower levels of preoperative miRNA-208a correlated with and could predict the appearance of postoperative cardiac and inflammatory complications. MiRNA-208a may serve as a biomarker for the prediction of patients who are at risk to develop complications following surgery for the repair of congenital heart defects.
机译:主要围手术期心血管事件是先天性心脏病患者的发病率的重要原因。目前的术前临床风险评估策略对鉴定患者患者在心脏手术后维持不良事件的患者具有较差的准确性。持续需要将临床变量与新颖的技术和生物标志物集成,以准确地预测在小儿心脏手术后的结果。我们测试了术前水平的miRNA-208a是否可以作为这样的生物标志物。在心脏手术前立即从儿科患者获得血清样品。 MiRNA-208A通过RQ-PCR定量。测试患者临床变量与miRNA水平之间的相关性。较低水平的术前miRNA-208a与术后心脏和炎症并发症的外观预测。 miRNA-208a可以作为预测有风险的患者的生物标志物,该患者在手术后进行患者修复先天性心脏缺陷。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号